Alzinova AB (publ) (STO:ALZ)
Sweden · Delayed Price · Currency is SEK 0.3355
-0.0070 (-2.04%)
Nov 3, 2026, 5:29 PM CET
Alzinova AB Market Cap
Alzinova AB has a market cap or net worth of 106.04 million as of November 3, 2026. It is the 40,922nd most valuable company in the world and the 588th biggest in Sweden. Its market cap has decreased by 32.95% in one year.
Market Cap
106.04M
Enterprise Value
93.53M
Revenue
149.00K
Global Rank
Country Rank
#588 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since November 25, 2015, Alzinova AB's market cap has increased from 57.35M to 106.04M, an increase of 84.90%. That is a compound annual growth rate of 5.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 106.04M | 22.61% |
| Dec 30, 2025 | 86.48M | -71.97% |
| Dec 30, 2024 | 308.51M | 128.27% |
| Dec 29, 2023 | 135.15M | 50.50% |
| Dec 30, 2022 | 89.80M | -11.61% |
| Dec 30, 2021 | 101.60M | -13.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 177.85M |
| Diamyd Medical AB | 152.19M |
| Simris Group AB (PUBL) | 151.85M |
| Abera Bioscience AB | 140.62M |
| Xintela AB | 122.73M |
| Initiator Pharma | 121.16M |
| Active Biotech AB | 107.68M |
| Biovica International AB | 104.50M |